Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK961081

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
To investigate the pharmacokinetics of inhaled batefenterol (BAT) and fluticasone furoate (FF) given alone or in combination via… Expand
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2015
2015
AbstractGSK961081 (batefenterol) is a novel bifunctional molecule composed of a muscarinic antagonist and a β2‐agonist. The aims… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2015
2015
Through application of our multivalent approach to drug discovery we previously reported the first discovery of dual pharmacology… Expand
Is this relevant?
2014
2014
OBJECTIVE To investigate the pharmacokinetics and pharmacodynamics of inhaled GSK961081 and fluticasone propionate (FP) given… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
2014
2014
PurposeThe objective of this study was to explore the pharmacology of GSK961081, a bi-functional bronchodilator, in healthy… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
GSK961081 is an inhaled bi-functional molecule with both muscarinic antagonism and β2-agonism (MABA) properties. This randomised… Expand
Is this relevant?
2013
2013
GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and β-agonist activities. This was a 4-week… Expand
Is this relevant?
2013
2013
BACKGROUND There are few data on the bronchodilatory effects of adding short-acting bronchodilators (SABA) to maintenance, long… Expand
Is this relevant?
2013
2013
The aim of this study was to characterise population pharmacokinetics (PK) and pharmacodynamics (PD) of GSK961081 (MABA), a bi… Expand
Is this relevant?
2011
2011
Introduction: GSK961081 is a dual pharmacophore with both muscarinic antagonist and beta 2 agonist (MABA) activity. Objective: To… Expand
Is this relevant?